Given that stroke involves BBB dysfunction and its extent may vary with infarct sizes, additional albumin administration for stroke patients may induce massive albumin exposure to broad brain regions, resulting in adverse events including intracerebral hemorrhage. This evidence concerns the gene ALB and intracerebral hemorrhage.